LATTICE SEMICONDUCTOR CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that LATTICE SEMICONDUCTOR CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 30, 2017 | $385.96M | Mar 14, 2018 |
| FY2017 | Dec 31, 2016 | $427.05M | Mar 14, 2018 |
| FY2017 | Jan 2, 2016 | $405.97M | Mar 14, 2018 |
| FY2016 | Jan 3, 2015 | $366.13M | Mar 1, 2017 |
| FY2014 | Dec 28, 2013 | $332.53M | Mar 2, 2016 |
| FY2014 | Dec 29, 2012 | $279.26M | Mar 4, 2015 |
| FY2013 | Dec 31, 2011 | $318.37M | Mar 11, 2014 |
| FY2012 | Jan 1, 2011 | $297.77M | Mar 8, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $523.26M | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | $509.40M | Feb 13, 2026 |
| FY2025 | Dec 30, 2023 | $737.15M | Feb 13, 2026 |
| FY2023 | Dec 31, 2022 | $660.36M | Feb 16, 2024 |
| FY2023 | Jan 1, 2022 | $515.33M | Feb 16, 2024 |
| FY2020 | Jan 2, 2021 | $107.17M | Feb 26, 2021 |
| FY2020 | Sep 26, 2020 | $103.04M | Feb 26, 2021 |
| FY2020 | Jun 27, 2020 | $100.59M | Feb 26, 2021 |
| FY2020 | Mar 28, 2020 | $97.32M | Feb 26, 2021 |
| FY2020 | Dec 28, 2019 | $100.24M | Feb 26, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 30, 2017 | $95.27M | Mar 14, 2018 |
| FY2017 | Sep 30, 2017 | $91.97M | Mar 14, 2018 |
| FY2017 | Jul 1, 2017 | $94.14M | Mar 14, 2018 |
| FY2017 | Apr 1, 2017 | $104.59M | Mar 14, 2018 |
| FY2017 | Dec 31, 2016 | $118.11M | Mar 14, 2018 |
| FY2017 | Oct 1, 2016 | $113.23M | Mar 14, 2018 |
| FY2017 | Jul 2, 2016 | $99.21M | Mar 14, 2018 |
| FY2017 | Apr 2, 2016 | $96.51M | Mar 14, 2018 |
| FY2016 | Jan 2, 2016 | $101.19M | Mar 1, 2017 |
| FY2016 | Oct 3, 2015 | $109.72M | Mar 1, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $356.94M | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | $340.40M | Feb 13, 2026 |
| FY2025 | Dec 30, 2023 | $514.67M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $452.05M | Feb 14, 2025 |
| FY2023 | Jan 1, 2022 | $321.68M | Feb 16, 2024 |
| FY2020 | Jan 2, 2021 | $64.86M | Feb 26, 2021 |
| FY2020 | Sep 26, 2020 | $62.31M | Feb 26, 2021 |
| FY2020 | Jun 27, 2020 | $60.58M | Feb 26, 2021 |
| FY2020 | Mar 28, 2020 | $57.56M | Feb 26, 2021 |
| FY2020 | Dec 28, 2019 | $59.29M | Feb 26, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $3.08M | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | $61.13M | Feb 13, 2026 |
| FY2025 | Dec 30, 2023 | $259.06M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $178.88M | Feb 14, 2025 |
| FY2023 | Jan 1, 2022 | $95.92M | Feb 16, 2024 |
| FY2020 | Jan 2, 2021 | $15.99M | Feb 26, 2021 |
| FY2020 | Sep 26, 2020 | $12.61M | Feb 26, 2021 |
| FY2020 | Jun 27, 2020 | $10.63M | Feb 26, 2021 |
| FY2020 | Mar 28, 2020 | $8.17M | Feb 26, 2021 |
| FY2020 | Dec 28, 2019 | $13.99M | Feb 26, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $11.23M | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | $34.46M | Feb 13, 2026 |
| FY2025 | Dec 30, 2023 | $212.27M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $187.37M | Feb 14, 2025 |
| FY2023 | Jan 1, 2022 | $100.82M | Feb 16, 2024 |
| FY2022 | Jan 2, 2021 | $52.37M | Feb 17, 2023 |
| FY2021 | Dec 28, 2019 | $59.04M | Feb 23, 2022 |
| FY2020 | Dec 29, 2018 | ($3.12M) | Feb 26, 2021 |
| FY2019 | Dec 30, 2017 | ($47.62M) | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | ($26.70M) | Feb 26, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $187.98M | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | $159.30M | Feb 13, 2026 |
| FY2025 | Dec 30, 2023 | $159.77M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $135.77M | Feb 14, 2025 |
| FY2023 | Jan 1, 2022 | $110.52M | Feb 16, 2024 |
| FY2022 | Jan 2, 2021 | $89.22M | Feb 17, 2023 |
| FY2021 | Dec 28, 2019 | $78.62M | Feb 23, 2022 |
| FY2020 | Dec 29, 2018 | $82.45M | Feb 26, 2021 |
| FY2019 | Dec 30, 2017 | $103.36M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $117.52M | Feb 26, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $153.63M | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | $116.94M | Feb 13, 2026 |
| FY2025 | Dec 30, 2023 | $137.24M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $122.08M | Feb 14, 2025 |
| FY2023 | Jan 1, 2022 | $105.62M | Feb 16, 2024 |
| FY2022 | Jan 2, 2021 | $95.33M | Feb 17, 2023 |
| FY2021 | Dec 28, 2019 | $82.54M | Feb 23, 2022 |
| FY2020 | Dec 29, 2018 | $91.05M | Feb 26, 2021 |
| FY2019 | Dec 30, 2017 | $90.72M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $98.60M | Feb 26, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $175.11M | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | $140.88M | Feb 13, 2026 |
| FY2025 | Dec 30, 2023 | $269.59M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $238.81M | Feb 14, 2025 |
| FY2023 | Jan 1, 2022 | $167.72M | Feb 16, 2024 |
| FY2022 | Jan 2, 2021 | $91.69M | Feb 17, 2023 |
| FY2021 | Dec 28, 2019 | $124.14M | Feb 23, 2022 |
| FY2020 | Dec 29, 2018 | $51.46M | Feb 26, 2021 |
| FY2019 | Dec 30, 2017 | $38.51M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $41.73M | Feb 26, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $42.53M | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | $20.99M | Feb 13, 2026 |
| FY2025 | Dec 30, 2023 | $20.10M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $23.34M | Feb 14, 2025 |
| FY2023 | Jan 1, 2022 | $9.84M | Feb 16, 2024 |
| FY2022 | Jan 2, 2021 | $12.12M | Feb 17, 2023 |
| FY2021 | Dec 28, 2019 | $15.59M | Feb 23, 2022 |
| FY2020 | Dec 29, 2018 | $8.38M | Feb 26, 2021 |
| FY2019 | Dec 30, 2017 | $12.86M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $16.72M | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $883.12M | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | $843.90M | Feb 13, 2026 |
| FY2024 | Dec 30, 2023 | $840.89M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $798.71M | Feb 16, 2024 |
| FY2022 | Jan 1, 2022 | $726.49M | Feb 17, 2023 |
| FY2021 | Jan 2, 2021 | $680.07M | Feb 23, 2022 |
| FY2020 | Dec 28, 2019 | $612.02M | Feb 26, 2021 |
| FY2019 | Dec 29, 2018 | $623.69M | Feb 24, 2020 |
| FY2018 | Dec 30, 2017 | $635.96M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $766.88M | Mar 14, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $169.07M | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | $132.97M | Feb 13, 2026 |
| FY2024 | Dec 30, 2023 | $148.87M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $311.55M | Feb 16, 2024 |
| FY2022 | Jan 1, 2022 | $314.86M | Feb 17, 2023 |
| FY2021 | Jan 2, 2021 | $295.64M | Feb 23, 2022 |
| FY2020 | Dec 28, 2019 | $284.36M | Feb 26, 2021 |
| FY2019 | Dec 29, 2018 | $365.23M | Feb 24, 2020 |
| FY2018 | Dec 30, 2017 | $418.27M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $496.45M | Mar 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $714.05M | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | $710.93M | Feb 13, 2026 |
| FY2025 | Dec 30, 2023 | $692.02M | Feb 13, 2026 |
| FY2025 | Dec 31, 2022 | $487.16M | Feb 13, 2026 |
| FY2024 | Jan 1, 2022 | $411.63M | Feb 14, 2025 |
| FY2023 | Jan 2, 2021 | $384.43M | Feb 16, 2024 |
| FY2022 | Dec 28, 2019 | $327.66M | Feb 17, 2023 |
| FY2021 | Dec 29, 2018 | $258.46M | Feb 23, 2022 |
| FY2020 | Dec 30, 2017 | $245.09M | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | $270.43M | Feb 24, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $315.36M | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | $315.36M | Feb 13, 2026 |
| FY2024 | Dec 30, 2023 | $315.36M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $315.36M | Feb 16, 2024 |
| FY2022 | Jan 1, 2022 | $315.36M | Feb 17, 2023 |
| FY2021 | Jan 2, 2021 | $267.51M | Feb 23, 2022 |
| FY2020 | Dec 28, 2019 | $267.51M | Feb 26, 2021 |
| FY2019 | Dec 29, 2018 | $267.51M | Feb 24, 2020 |
| FY2018 | Dec 30, 2017 | $267.51M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $269.76M | Mar 14, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $212.18M | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | $209.10M | Feb 13, 2026 |
| FY2024 | Dec 30, 2023 | $147.97M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | ($111.09M) | Feb 16, 2024 |
| FY2022 | Jan 1, 2022 | ($289.98M) | Feb 17, 2023 |
| FY2021 | Jan 2, 2021 | ($385.90M) | Feb 23, 2022 |
| FY2020 | Dec 28, 2019 | ($433.29M) | Feb 26, 2021 |
| FY2019 | Dec 29, 2018 | ($476.78M) | Feb 24, 2020 |
| FY2018 | Dec 30, 2017 | ($477.86M) | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | ($406.95M) | Mar 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $133.89M | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | $136.29M | Feb 13, 2026 |
| FY2024 | Dec 30, 2023 | $128.32M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $145.72M | Feb 16, 2024 |
| FY2022 | Jan 1, 2022 | $131.57M | Feb 17, 2023 |
| FY2021 | Jan 2, 2021 | $182.33M | Feb 23, 2022 |
| FY2020 | Dec 28, 2019 | $118.08M | Feb 26, 2021 |
| FY2019 | Dec 29, 2018 | $119.05M | Feb 24, 2020 |
| FY2018 | Dec 30, 2017 | $106.82M | Feb 26, 2019 |
| FY2018 | Dec 31, 2016 | $106.55M | Feb 26, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Jan 1, 2022 | $158.75M | Feb 23, 2022 |
| FY2020 | Jan 2, 2021 | $171.88M | Feb 26, 2021 |
| FY2019 | Dec 28, 2019 | $125.07M | Feb 24, 2020 |
| FY2019 | Dec 29, 2018 | $251.36M | Feb 24, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | 0 | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | 0 | Feb 13, 2026 |
| FY2025 | Dec 30, 2023 | 1 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 14, 2025 |
| FY2023 | Jan 1, 2022 | 0 | Feb 16, 2024 |
| FY2020 | Jan 2, 2021 | 0 | Feb 26, 2021 |
| FY2020 | Sep 26, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Jun 27, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Mar 28, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 28, 2019 | 0 | Feb 26, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | 0 | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | 0 | Feb 13, 2026 |
| FY2025 | Dec 30, 2023 | 1 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 14, 2025 |
| FY2023 | Jan 1, 2022 | 0 | Feb 16, 2024 |
| FY2020 | Jan 2, 2021 | 0 | Feb 26, 2021 |
| FY2020 | Sep 26, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Jun 27, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Mar 28, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 28, 2019 | 0 | Feb 26, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | 136.77M | Feb 13, 2026 |
| FY2025 | Dec 28, 2024 | 137.70M | Feb 13, 2026 |
| FY2024 | Dec 30, 2023 | 137.34M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | 137.10M | Feb 16, 2024 |
| FY2022 | Jan 1, 2022 | 137.24M | Feb 17, 2023 |
| FY2021 | Jan 2, 2021 | 136.24M | Feb 23, 2022 |
| FY2020 | Dec 28, 2019 | 133.88M | Feb 26, 2021 |
| FY2019 | Dec 29, 2018 | 129.73M | Feb 24, 2020 |
| FY2018 | Dec 30, 2017 | 123.90M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | 121.65M | Mar 14, 2018 |